{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Trial Duration</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>Tufts Medical Center|National Institutes of He...</td>\n",
       "      <td>...</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>235</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18-Feb-21</td>\n",
       "      <td>Tufts Medical Center, Boston, Massachusetts, U...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04425538</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>Vicore Pharma AB|Orphan Reach</td>\n",
       "      <td>...</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>84</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>30-Jun-20</td>\n",
       "      <td>30-Apr-21</td>\n",
       "      <td>30-Apr-21</td>\n",
       "      <td>Department of Medicine, Civil Hospital and B J...</td>\n",
       "      <td>\"Study Protocol and Statistical Analysis Plan\"...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04452435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic...</td>\n",
       "      <td>...</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>215</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>24-Jun-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3-Feb-21</td>\n",
       "      <td>Hospital Universitario de CabueÃ±es, GijÃ³n, A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04445272</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>Universidade Nova de Lisboa|NOVA Medical Schoo...</td>\n",
       "      <td>...</td>\n",
       "      <td>16-Jul-20</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>87</td>\n",
       "      <td>1-Jul-20</td>\n",
       "      <td>21-Apr-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>25-Aug-20</td>\n",
       "      <td>Hospital CUF Infante Santo, S.A., Lisbon, Port...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04355741</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>Liaquat University of Medical &amp; Health Sciences</td>\n",
       "      <td>...</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>198</td>\n",
       "      <td>28-Mar-21</td>\n",
       "      <td>8-Oct-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>22-Apr-21</td>\n",
       "      <td>Liaquat University Hospital, JÄmshoro, Sindh,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04578158</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 28 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1     2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2     3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3     4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4     5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "\n",
       "  Acronym     Status         Study Results Conditions  \\\n",
       "0     NaN  Completed  No Results Available   COVID-19   \n",
       "1     NaN  Completed           Has Results   COVID-19   \n",
       "2     NaN  Completed  No Results Available   COVID-19   \n",
       "3     NaN  Completed  No Results Available   COVID-19   \n",
       "4     NaN  Completed  No Results Available   COVID-19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   Drug: Infliximab   \n",
       "1                            Drug: C21|Drug: Placebo   \n",
       "2                                  Drug: Tocilizumab   \n",
       "3                                    Other: Exposure   \n",
       "4  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "                                    Outcome Measures  \\\n",
       "0  Time to improvement in oxygenation|28-day mort...   \n",
       "1  Change From Baseline in C-reactive Protein (CR...   \n",
       "2  To calulate the time of intubation|To calculat...   \n",
       "3  Differences in gut microbiota composition betw...   \n",
       "4  Percentage of subjects with COVID-19 disease p...   \n",
       "\n",
       "                               Sponsor/Collaborators  ... Completion Date  \\\n",
       "0  Tufts Medical Center|National Institutes of He...  ...       22-Jan-21   \n",
       "1                      Vicore Pharma AB|Orphan Reach  ...       13-Oct-20   \n",
       "2  Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic...  ...       23-Dec-20   \n",
       "3  Universidade Nova de Lisboa|NOVA Medical Schoo...  ...       16-Jul-20   \n",
       "4    Liaquat University of Medical & Health Sciences  ...       15-Apr-21   \n",
       "\n",
       "  Start Date Trial Duration  Primary Completion Date First Posted  \\\n",
       "0   1-Jun-20            235                22-Jan-21    11-Jun-20   \n",
       "1  21-Jul-20             84                13-Oct-20    30-Jun-20   \n",
       "2  22-May-20            215                23-Dec-20    24-Jun-20   \n",
       "3  20-Apr-20             87                 1-Jul-20    21-Apr-20   \n",
       "4  29-Sep-20            198                28-Mar-21     8-Oct-20   \n",
       "\n",
       "  Results First Posted Last Update Posted  \\\n",
       "0                  NaN          18-Feb-21   \n",
       "1            30-Apr-21          30-Apr-21   \n",
       "2                  NaN           3-Feb-21   \n",
       "3                  NaN          25-Aug-20   \n",
       "4                  NaN          22-Apr-21   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  Tufts Medical Center, Boston, Massachusetts, U...   \n",
       "1  Department of Medicine, Civil Hospital and B J...   \n",
       "2  Hospital Universitario de CabueÃ±es, GijÃ³n, A...   \n",
       "3  Hospital CUF Infante Santo, S.A., Lisbon, Port...   \n",
       "4  Liaquat University Hospital, JÄmshoro, Sindh,...   \n",
       "\n",
       "                                     Study Documents  \\\n",
       "0                                                NaN   \n",
       "1  \"Study Protocol and Statistical Analysis Plan\"...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "\n",
       "                                           URL  \n",
       "0  https://ClinicalTrials.gov/show/NCT04425538  \n",
       "1  https://ClinicalTrials.gov/show/NCT04452435  \n",
       "2  https://ClinicalTrials.gov/show/NCT04445272  \n",
       "3  https://ClinicalTrials.gov/show/NCT04355741  \n",
       "4  https://ClinicalTrials.gov/show/NCT04578158  \n",
       "\n",
       "[5 rows x 28 columns]"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "from matplotlib.ticker import StrMethodFormatter\n",
    "import numpy as np\n",
    "import seaborn as sns\n",
    "\n",
    "# Load the CSV (load date data as proper date types)\n",
    "covid = \"~/desktop/clinical-trial_data.csv\"\n",
    "\n",
    "# Use Pandas to read data\n",
    "covid_df = pd.read_csv(covid)\n",
    "covid_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Trial Duration</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>Tufts Medical Center|National Institutes of He...</td>\n",
       "      <td>...</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>235</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18-Feb-21</td>\n",
       "      <td>Tufts Medical Center, Boston, Massachusetts, U...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04425538</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>Vicore Pharma AB|Orphan Reach</td>\n",
       "      <td>...</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>84</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>30-Jun-20</td>\n",
       "      <td>30-Apr-21</td>\n",
       "      <td>30-Apr-21</td>\n",
       "      <td>Department of Medicine, Civil Hospital and B J...</td>\n",
       "      <td>\"Study Protocol and Statistical Analysis Plan\"...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04452435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic...</td>\n",
       "      <td>...</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>215</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>24-Jun-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3-Feb-21</td>\n",
       "      <td>Hospital Universitario de CabueÃ±es, GijÃ³n, A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04445272</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>Universidade Nova de Lisboa|NOVA Medical Schoo...</td>\n",
       "      <td>...</td>\n",
       "      <td>16-Jul-20</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>87</td>\n",
       "      <td>1-Jul-20</td>\n",
       "      <td>21-Apr-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>25-Aug-20</td>\n",
       "      <td>Hospital CUF Infante Santo, S.A., Lisbon, Port...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04355741</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>Liaquat University of Medical &amp; Health Sciences</td>\n",
       "      <td>...</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>198</td>\n",
       "      <td>28-Mar-21</td>\n",
       "      <td>8-Oct-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>22-Apr-21</td>\n",
       "      <td>Liaquat University Hospital, JÄmshoro, Sindh,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04578158</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 28 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1     2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2     3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3     4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4     5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "\n",
       "  Acronym     Status         Study Results Conditions  \\\n",
       "0     NaN  Completed  No Results Available   COVID-19   \n",
       "1     NaN  Completed           Has Results   COVID-19   \n",
       "2     NaN  Completed  No Results Available   COVID-19   \n",
       "3     NaN  Completed  No Results Available   COVID-19   \n",
       "4     NaN  Completed  No Results Available   COVID-19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   Drug: Infliximab   \n",
       "1                            Drug: C21|Drug: Placebo   \n",
       "2                                  Drug: Tocilizumab   \n",
       "3                                    Other: Exposure   \n",
       "4  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "                                    Outcome Measures  \\\n",
       "0  Time to improvement in oxygenation|28-day mort...   \n",
       "1  Change From Baseline in C-reactive Protein (CR...   \n",
       "2  To calulate the time of intubation|To calculat...   \n",
       "3  Differences in gut microbiota composition betw...   \n",
       "4  Percentage of subjects with COVID-19 disease p...   \n",
       "\n",
       "                               Sponsor/Collaborators  ... Completion Date  \\\n",
       "0  Tufts Medical Center|National Institutes of He...  ...       22-Jan-21   \n",
       "1                      Vicore Pharma AB|Orphan Reach  ...       13-Oct-20   \n",
       "2  Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic...  ...       23-Dec-20   \n",
       "3  Universidade Nova de Lisboa|NOVA Medical Schoo...  ...       16-Jul-20   \n",
       "4    Liaquat University of Medical & Health Sciences  ...       15-Apr-21   \n",
       "\n",
       "  Start Date Trial Duration  Primary Completion Date First Posted  \\\n",
       "0   1-Jun-20            235                22-Jan-21    11-Jun-20   \n",
       "1  21-Jul-20             84                13-Oct-20    30-Jun-20   \n",
       "2  22-May-20            215                23-Dec-20    24-Jun-20   \n",
       "3  20-Apr-20             87                 1-Jul-20    21-Apr-20   \n",
       "4  29-Sep-20            198                28-Mar-21     8-Oct-20   \n",
       "\n",
       "  Results First Posted Last Update Posted  \\\n",
       "0                  NaN          18-Feb-21   \n",
       "1            30-Apr-21          30-Apr-21   \n",
       "2                  NaN           3-Feb-21   \n",
       "3                  NaN          25-Aug-20   \n",
       "4                  NaN          22-Apr-21   \n",
       "\n",
       "                                           Locations  \\\n",
       "0  Tufts Medical Center, Boston, Massachusetts, U...   \n",
       "1  Department of Medicine, Civil Hospital and B J...   \n",
       "2  Hospital Universitario de CabueÃ±es, GijÃ³n, A...   \n",
       "3  Hospital CUF Infante Santo, S.A., Lisbon, Port...   \n",
       "4  Liaquat University Hospital, JÄmshoro, Sindh,...   \n",
       "\n",
       "                                     Study Documents  \\\n",
       "0                                                NaN   \n",
       "1  \"Study Protocol and Statistical Analysis Plan\"...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "\n",
       "                                           URL  \n",
       "0  https://ClinicalTrials.gov/show/NCT04425538  \n",
       "1  https://ClinicalTrials.gov/show/NCT04452435  \n",
       "2  https://ClinicalTrials.gov/show/NCT04445272  \n",
       "3  https://ClinicalTrials.gov/show/NCT04355741  \n",
       "4  https://ClinicalTrials.gov/show/NCT04578158  \n",
       "\n",
       "[5 rows x 28 columns]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Clean Rows with Missing Data\n",
    "covid_df.count()\n",
    "cleaned_data_df = covid_df.dropna(how='any')\n",
    "cleaned_data_df.count()\n",
    "covid_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1117"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Calculate Total Number of Trials \n",
    "total_trials = len(covid_df['NCT Number'].value_counts())\n",
    "total_trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "326"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Calculate Total Number of Days\n",
    "total_days = len(covid_df['Trial Duration'].value_counts())\n",
    "total_days "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Trial Duration</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>URL</th>\n",
       "      <th>Trial Duration (Weeks)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>A Phase 2 Trial of Infliximab in Coronavirus D...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>Tufts Medical Center|National Institutes of He...</td>\n",
       "      <td>...</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>235</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>18-Feb-21</td>\n",
       "      <td>Tufts Medical Center, Boston, Massachusetts, U...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04425538</td>\n",
       "      <td>33.571429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Safety and Efficacy of C21 in Subjects With CO...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>Vicore Pharma AB|Orphan Reach</td>\n",
       "      <td>...</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>84</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>30-Jun-20</td>\n",
       "      <td>30-Apr-21</td>\n",
       "      <td>30-Apr-21</td>\n",
       "      <td>Department of Medicine, Civil Hospital and B J...</td>\n",
       "      <td>\"Study Protocol and Statistical Analysis Plan\"...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04452435</td>\n",
       "      <td>12.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Clinical Trial to Evaluate the Effectiveness a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic...</td>\n",
       "      <td>...</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>215</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>24-Jun-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3-Feb-21</td>\n",
       "      <td>Hospital Universitario de CabueÃ±es, GijÃ³n, A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04445272</td>\n",
       "      <td>30.714286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Gut Microbiota, \"Spark and Flame\" of COVID-19 ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>Universidade Nova de Lisboa|NOVA Medical Schoo...</td>\n",
       "      <td>...</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>87</td>\n",
       "      <td>1-Jul-20</td>\n",
       "      <td>21-Apr-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>25-Aug-20</td>\n",
       "      <td>Hospital CUF Infante Santo, S.A., Lisbon, Port...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04355741</td>\n",
       "      <td>12.428571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Trial to Study the Adjuvant Benefits of Querce...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>Liaquat University of Medical &amp; Health Sciences</td>\n",
       "      <td>...</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>198</td>\n",
       "      <td>28-Mar-21</td>\n",
       "      <td>8-Oct-20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>22-Apr-21</td>\n",
       "      <td>Liaquat University Hospital, JÄmshoro, Sindh,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT04578158</td>\n",
       "      <td>28.285714</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 29 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number                                              Title  \\\n",
       "0     1  NCT04425538  A Phase 2 Trial of Infliximab in Coronavirus D...   \n",
       "1     2  NCT04452435  Safety and Efficacy of C21 in Subjects With CO...   \n",
       "2     3  NCT04445272  Clinical Trial to Evaluate the Effectiveness a...   \n",
       "3     4  NCT04355741  Gut Microbiota, \"Spark and Flame\" of COVID-19 ...   \n",
       "4     5  NCT04578158  Trial to Study the Adjuvant Benefits of Querce...   \n",
       "\n",
       "  Acronym     Status         Study Results Conditions  \\\n",
       "0     NaN  Completed  No Results Available   COVID-19   \n",
       "1     NaN  Completed           Has Results   COVID-19   \n",
       "2     NaN  Completed  No Results Available   COVID-19   \n",
       "3     NaN  Completed  No Results Available   COVID-19   \n",
       "4     NaN  Completed  No Results Available   COVID-19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   Drug: Infliximab   \n",
       "1                            Drug: C21|Drug: Placebo   \n",
       "2                                  Drug: Tocilizumab   \n",
       "3                                    Other: Exposure   \n",
       "4  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "                                    Outcome Measures  \\\n",
       "0  Time to improvement in oxygenation|28-day mort...   \n",
       "1  Change From Baseline in C-reactive Protein (CR...   \n",
       "2  To calulate the time of intubation|To calculat...   \n",
       "3  Differences in gut microbiota composition betw...   \n",
       "4  Percentage of subjects with COVID-19 disease p...   \n",
       "\n",
       "                               Sponsor/Collaborators  ... Start Date  \\\n",
       "0  Tufts Medical Center|National Institutes of He...  ...   1-Jun-20   \n",
       "1                      Vicore Pharma AB|Orphan Reach  ...  21-Jul-20   \n",
       "2  Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic...  ...  22-May-20   \n",
       "3  Universidade Nova de Lisboa|NOVA Medical Schoo...  ...  20-Apr-20   \n",
       "4    Liaquat University of Medical & Health Sciences  ...  29-Sep-20   \n",
       "\n",
       "  Trial Duration Primary Completion Date  First Posted Results First Posted  \\\n",
       "0            235               22-Jan-21     11-Jun-20                  NaN   \n",
       "1             84               13-Oct-20     30-Jun-20            30-Apr-21   \n",
       "2            215               23-Dec-20     24-Jun-20                  NaN   \n",
       "3             87                1-Jul-20     21-Apr-20                  NaN   \n",
       "4            198               28-Mar-21      8-Oct-20                  NaN   \n",
       "\n",
       "  Last Update Posted                                          Locations  \\\n",
       "0          18-Feb-21  Tufts Medical Center, Boston, Massachusetts, U...   \n",
       "1          30-Apr-21  Department of Medicine, Civil Hospital and B J...   \n",
       "2           3-Feb-21  Hospital Universitario de CabueÃ±es, GijÃ³n, A...   \n",
       "3          25-Aug-20  Hospital CUF Infante Santo, S.A., Lisbon, Port...   \n",
       "4          22-Apr-21  Liaquat University Hospital, JÄmshoro, Sindh,...   \n",
       "\n",
       "                                     Study Documents  \\\n",
       "0                                                NaN   \n",
       "1  \"Study Protocol and Statistical Analysis Plan\"...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "\n",
       "                                           URL Trial Duration (Weeks)  \n",
       "0  https://ClinicalTrials.gov/show/NCT04425538              33.571429  \n",
       "1  https://ClinicalTrials.gov/show/NCT04452435              12.000000  \n",
       "2  https://ClinicalTrials.gov/show/NCT04445272              30.714286  \n",
       "3  https://ClinicalTrials.gov/show/NCT04355741              12.428571  \n",
       "4  https://ClinicalTrials.gov/show/NCT04578158              28.285714  \n",
       "\n",
       "[5 rows x 29 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Converting the trial days into weeks and then adding a column to the DataFrame\n",
    "weeks = covid_df[\"Trial Duration\"]/7\n",
    "covid_df[\"Trial Duration (Weeks)\"] = weeks\n",
    "\n",
    "covid_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Status</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Trial Duration</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Trial Duration (Weeks)</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Infliximab</td>\n",
       "      <td>Time to improvement in oxygenation|28-day mort...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older Â  (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>17</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>22-Jan-21</td>\n",
       "      <td>1-Jun-20</td>\n",
       "      <td>235</td>\n",
       "      <td>11-Jun-20</td>\n",
       "      <td>Tufts Medical Center, Boston, Massachusetts, U...</td>\n",
       "      <td>33.571429</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: C21|Drug: Placebo</td>\n",
       "      <td>Change From Baseline in C-reactive Protein (CR...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 70 Years Â  (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>206</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>13-Oct-20</td>\n",
       "      <td>21-Jul-20</td>\n",
       "      <td>84</td>\n",
       "      <td>30-Jun-20</td>\n",
       "      <td>Department of Medicine, Civil Hospital and B J...</td>\n",
       "      <td>12.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Tocilizumab</td>\n",
       "      <td>To calulate the time of intubation|To calculat...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older Â  (Adult, Older Adult)</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>495</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>23-Dec-20</td>\n",
       "      <td>22-May-20</td>\n",
       "      <td>215</td>\n",
       "      <td>24-Jun-20</td>\n",
       "      <td>Hospital Universitario de CabueÃ±es, GijÃ³n, A...</td>\n",
       "      <td>30.714286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Other: Exposure</td>\n",
       "      <td>Differences in gut microbiota composition betw...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older Â  (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>115</td>\n",
       "      <td>Observational</td>\n",
       "      <td>16-Jul-20</td>\n",
       "      <td>20-Apr-20</td>\n",
       "      <td>87</td>\n",
       "      <td>21-Apr-20</td>\n",
       "      <td>Hospital CUF Infante Santo, S.A., Lisbon, Port...</td>\n",
       "      <td>12.428571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5</td>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>Completed</td>\n",
       "      <td>COVID-19</td>\n",
       "      <td>Drug: Standard COVID-19 care|Dietary Supplemen...</td>\n",
       "      <td>Percentage of subjects with COVID-19 disease p...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older Â  (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>152</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>15-Apr-21</td>\n",
       "      <td>29-Sep-20</td>\n",
       "      <td>198</td>\n",
       "      <td>8-Oct-20</td>\n",
       "      <td>Liaquat University Hospital, JÄmshoro, Sindh,...</td>\n",
       "      <td>28.285714</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Rank   NCT Number     Status Conditions  \\\n",
       "0     1  NCT04425538  Completed   COVID-19   \n",
       "1     2  NCT04452435  Completed   COVID-19   \n",
       "2     3  NCT04445272  Completed   COVID-19   \n",
       "3     4  NCT04355741  Completed   COVID-19   \n",
       "4     5  NCT04578158  Completed   COVID-19   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                                   Drug: Infliximab   \n",
       "1                            Drug: C21|Drug: Placebo   \n",
       "2                                  Drug: Tocilizumab   \n",
       "3                                    Other: Exposure   \n",
       "4  Drug: Standard COVID-19 care|Dietary Supplemen...   \n",
       "\n",
       "                                    Outcome Measures Gender  \\\n",
       "0  Time to improvement in oxygenation|28-day mort...    All   \n",
       "1  Change From Baseline in C-reactive Protein (CR...    All   \n",
       "2  To calulate the time of intubation|To calculat...    All   \n",
       "3  Differences in gut microbiota composition betw...    All   \n",
       "4  Percentage of subjects with COVID-19 disease p...    All   \n",
       "\n",
       "                                            Age   Phases  Enrollment  \\\n",
       "0    18 Years and older Â  (Adult, Older Adult)  Phase 2          17   \n",
       "1  18 Years to 70 Years Â  (Adult, Older Adult)  Phase 2         206   \n",
       "2    18 Years and older Â  (Adult, Older Adult)  Phase 2         495   \n",
       "3    18 Years and older Â  (Adult, Older Adult)      NaN         115   \n",
       "4    18 Years and older Â  (Adult, Older Adult)  Phase 3         152   \n",
       "\n",
       "       Study Type Completion Date Start Date  Trial Duration First Posted  \\\n",
       "0  Interventional       22-Jan-21   1-Jun-20             235    11-Jun-20   \n",
       "1  Interventional       13-Oct-20  21-Jul-20              84    30-Jun-20   \n",
       "2  Interventional       23-Dec-20  22-May-20             215    24-Jun-20   \n",
       "3   Observational       16-Jul-20  20-Apr-20              87    21-Apr-20   \n",
       "4  Interventional       15-Apr-21  29-Sep-20             198     8-Oct-20   \n",
       "\n",
       "                                           Locations  Trial Duration (Weeks)  \n",
       "0  Tufts Medical Center, Boston, Massachusetts, U...               33.571429  \n",
       "1  Department of Medicine, Civil Hospital and B J...               12.000000  \n",
       "2  Hospital Universitario de CabueÃ±es, GijÃ³n, A...               30.714286  \n",
       "3  Hospital CUF Infante Santo, S.A., Lisbon, Port...               12.428571  \n",
       "4  Liaquat University Hospital, JÄmshoro, Sindh,...               28.285714  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Remove Several Columns\n",
    "remove_columns = covid_df.drop(columns=['Title','Acronym', 'Study Results','Sponsor/Collaborators', 'Funded Bys','Study Designs', 'Other IDs', 'Primary Completion Date', 'Results First Posted', 'Last Update Posted', 'Study Documents', 'URL'])\n",
    "remove_columns.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Trial Duration</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT04425538</td>\n",
       "      <td>235</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04452435</td>\n",
       "      <td>84</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04445272</td>\n",
       "      <td>215</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04355741</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04578158</td>\n",
       "      <td>198</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    NCT Number  Trial Duration\n",
       "0  NCT04425538             235\n",
       "1  NCT04452435              84\n",
       "2  NCT04445272             215\n",
       "3  NCT04355741              87\n",
       "4  NCT04578158             198"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Reorganizing the columns using double brackets\n",
    "covid_df = covid_df[[\"NCT Number\",\"Trial Duration\"]]\n",
    "covid_df.head() "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 648x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "x = covid_df.groupby('NCT Number')['Trial Duration'].mean().sort_values().tail(10)\n",
    "\n",
    "ax = x.plot(kind='barh', figsize=(9, 10), color='#00C7C2', zorder=2, width=0.85)\n",
    "\n",
    "\n",
    "# Switch off ticks\n",
    "ax.tick_params(axis=\"both\", which=\"both\", bottom=\"off\", top=\"off\", labelbottom=\"on\", left=\"off\", right=\"off\", labelleft=\"on\")\n",
    "\n",
    "# Draw vertical axis lines\n",
    "vals = ax.get_xticks()\n",
    "for tick in vals:\n",
    "    ax.axvline(x=tick, linestyle='dashed', alpha=0.7, color='#eeeeee', zorder=1)\n",
    "\n",
    "# Set Bar Title\n",
    "ax.set_title(\"Covid-19 Clinical Trial Length In Days\", weight='bold', size=15)\n",
    "\n",
    "# Set x-axis label\n",
    "ax.set_xlabel(\"Trial Duration\", labelpad=10, weight='bold', size=13)\n",
    "\n",
    "# Set y-axis label\n",
    "ax.set_ylabel(\"Trials\", labelpad=10, weight='bold', size=13)\n",
    "\n",
    "# Add annotation to bars\n",
    "for i in ax.patches:\n",
    "    plt.text(i.get_width()+0.2, i.get_y()+0.5,\n",
    "             str(round((i.get_width()), 2)),\n",
    "             fontsize = 10, fontweight ='bold', color ='black')\n",
    "# Show Plot\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The longest trial (NCT04809480) lasted 1460 days. While the shortest trial lasted only a few hours.\n"
     ]
    }
   ],
   "source": [
    "print (f'The longest trial (NCT04809480) lasted 1460 days. While the shortest trial lasted only a few hours.')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
